(Q36316798)

13 August 2017

1 reference

title

Delivery of Chlamydia vaccines (English)

1 reference

13 August 2017

Adolfo Garcia-Sastre

6

0 references

Claudiu Bandea

4

object named as

Claudiu Bandea

1 reference

13 August 2017

Joseph Igietseme

1

1 reference

13 August 2017

Francis Eko

2

1 reference

13 August 2017

Qing He

3

1 reference

13 August 2017

Werner Lubitz

5

1 reference

13 August 2017

Carolyn Black

7

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

Expert Opinion on Drug Delivery

13 August 2017

published in

1 reference

13 August 2017

volume

2

1 reference

13 August 2017

issue

3

1 reference

13 August 2017

page(s)

549-562

1 reference

Molecular evolution of the Chlamydiaceae

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Radical changes to chlamydial taxonomy are not necessary just yet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

High-resolution mapping of serovar-specific and common antigenic determinants of the major outer membrane protein of Chlamydia trachomatis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Typing of Chlamydia trachomatis strains from urine samples by amplification and sequencing the major outer membrane protein gene (omp1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Effect of Treatment Regimens forNeisseria gonorrhoeaeon Simultaneous Infection withChlamydia trachomatis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Resurgence of lymphogranuloma venereum in Western Europe: an outbreak of Chlamydia trachomatis serovar l2 proctitis in The Netherlands among men who have sex with men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Chlamydia trachomatis and Mycobacterium tuberculosis lung infection in an HIV-positive homosexual man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Effect of Chlamydia trachomatis coinfection on HIV shedding in genital tract secretions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Treatment of cervicitis is associated with decreased cervical shedding of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Clinical manifestations of Chlamydia pneumoniae infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

NAATs to diagnose Chlamydia trachomatis genital infection: a promise still unfulfilled

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Does clinical diagnosis indicate ocular chlamydial infection in areas with a low prevalence of trachoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Electron microscopic evidence of persistent chlamydial infection following treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Chlamydial treatment failures: a persistent problem?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Evidence for long-term cervical persistence of Chlamydia trachomatis by omp1 genotyping

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

OmpA genotypic evidence for persistent ocular Chlamydia trachomatis infection in Tanzanian village women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

What sexually transmitted disease screening method does the adolescent prefer? Adolescents' attitudes toward first-void urine, self-collected vaginal swab, and pelvic examination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Pooling of Chlamydia laboratory tests to determine the prevalence of ocular Chlamydia trachomatis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Chlamydial genovar distribution after community wide antibiotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Should trachoma be treated with antibiotics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

A new computer model for estimating the impact of vaccination protocols and its application to the study of Chlamydia trachomatis genital infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Contemporary approaches to designing and evaluating vaccines against Chlamydia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Immunity to murine chlamydial genital infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

T cell responses to Chlamydia trachomatis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Antibody regulation of Tcell immunity: implications for vaccine strategies against intracellular pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

The role of IFN-gamma in the outcome of chlamydial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

The role of interleukin-12 in human infectious diseases: only a faint signature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Comparative genomes of Chlamydia pneumoniae and C. trachomatis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Chlamydial genomics and vaccine antigen discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Genome Sequence of an Obligate Intracellular Pathogen of Humans: Chlamydia trachomatis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Chlamydia trachomatis cytotoxicity associated with complete and partial cytotoxin genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Single channel analysis of recombinant major outer membrane protein porins from Chlamydia psittaci and Chlamydia pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Priming with Chlamydia trachomatis major outer membrane protein (MOMP) DNA followed by MOMP ISCOM boosting enhances protection and is associated with increased immunoglobulin A and Th1 cellular immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Genomic approach for analysis of surface proteins in Chlamydia pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Genome sequencing and our understanding of chlamydiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Chlamydia outer membrane protein discovery using genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Antigenic topology of chlamydial PorB protein and identification of targets for immune neutralization of infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Use of a mouse lung challenge model to identify antigens protective against Chlamydia pneumoniae lung infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Mucosal and systemic immune responses to plasmid protein pgp3 in patients with genital and ocular Chlamydia trachomatis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

DNA immunization with pgp3 gene of Chlamydia trachomatis inhibits the spread of chlamydial infection from the lower to the upper genital tract in C3H/HeN mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Human antibody responses to a Chlamydia-secreted protease factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Interaction between components of the type III secretion system of Chlamydiaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Characterization of Chlamydial Genital Infection Resulting from Sexual Transmission from Male to Female Guinea Pigs and Determination of Infectious Dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Antigen delivery systems and immunostimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Recent advances and novel strategies in vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Vaccine candidates in STD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Suppression of endogenous IL-10 gene expression in dendritic cells enhances antigen presentation for specific Th1 induction: potential for cellular vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Protective DNA immunization against Chlamydia pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

The potential for vaccine development against chlamydial infection and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Transgene as vaccine for chlamydia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Multiple Chlamydia pneumoniae antigens prime CD8+ Tc1 responses that inhibit intracellular growth of this vacuolar pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

DNA vaccines: immunology, application, and optimization*

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Turkeys are protected from infection with Chlamydia psittaci by plasmid DNA vaccination against the major outer membrane protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Vaccines against Chlamydia: approaches and progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Vaccination of mice with DNA plasmids coding for the Chlamydia trachomatis major outer membrane protein elicits an immune response but fails to protect against a genital challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

GM-CSF transgene-based adjuvant allows the establishment of protective mucosal immunity following vaccination with inactivated Chlamydia trachomatis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

An Inclusion Membrane Protein from Chlamydia trachomatis Enters the MHC Class I Pathway and Stimulates a CD8+ T Cell Response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Adenoviruses as vectors for delivering vaccines to mucosal surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

RNA viruses: emerging vectors for vaccination and gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Alphavirus vectors for gene expression and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Advances in vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein by use of CpG oligodeoxynucleotides as an adjuvant induces a protective immune response against an intranasal chlamydial challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Immunization with the Chlamydia trachomatis major outer membrane protein, using the outer surface protein A of Borrelia burgdorferi as an adjuvant, can induce protection against a chlamydial genital challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Delivery of protein antigens and DNA by virulence-attenuated strains of Salmonella typhimurium and Listeria monocytogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

New strategies for combination vaccines based on the extended recombinant bacterial ghost system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Chlamydia vaccines: strategies and status

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Dendritic cells as natural adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

The effect of trachoma virus vaccine on the course of experimental trachoma infection in blind human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Fc receptor regulation of protective immunity against Chlamydia trachomatis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Fc receptor-mediated antibody regulation of T cell immunity against intracellular pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Oral immunization with an anti-idiotypic antibody to the exoglycolipid antigen protects against experimental Chlamydia trachomatis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

The anti-idiotypic antibody to chlamydial glycolipid exoantigen (GLXA) protects mice against genital infection with a human biovar of Chlamydia trachomatis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Toll-like receptors; their physiological role and signal transduction system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Lipopeptide vaccines--yesterday, today, and tomorrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Mucosal immunity: implications for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

The mucosal immune system: from fundamental concepts to vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Induction of antibody-secreting cells and T-helper and memory cells in murine nasal lymphoid tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Inflammation and clearance of Chlamydia trachomatis in enteric and nonenteric mucosae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Exploitation of nucleic acid packaging signals to generate a novel influenza virus-based vector stably expressing two foreign genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

21 January 2018

Lymphogranuloma venereum

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2.3.549

21 January 2018

Identifiers

DOI

10.1517/17425247.2.3.549

1 reference

release_w43ijurh6jf3xk7xuxnhxziixe

13 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/w43ijurh6jf3xk7xuxnhxziixe

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference